Targeted re-biopsy of unambiguous (peripheral) PI-RADS-4-lesions is recommended; whereas transition zone confined PI-RADS-4-lesions with overlaying signs of ...

14 июн. 2023 г. · PI-RADS 4 lesions are considered to have a “high” likelihood of clinically-significant prostate cancer (csPCa). However, patients undergoing ...

Targeted re-biopsy of unambiguous (peripheral) PI-RADS-4-lesions is recommended; whereas transition zone confined PI-RADS-4-lesions with overlaying signs of ...

14 мар. 2022 г. · Samir S. Taneja, MD, discusses how to approach a negative MRI-targeted prostate biopsy in men with PI-RADS 4 or 5 lesions.

... PI-RADS score on a prostate MRI can guide further testing for prostate cancer diagnosis. Learn about the scoring system, biopsy results, and treatment options.

15 февр. 2020 г. · Biopsy is recommended for PI-RADS 4 and 5 lesions [13,14], which frequently need definitive treatment rather than active surveillance because ...

5 июл. 2024 г. · For patients with PI-RADS 4 lesions, the positive predictive value of [18F]DCFPyL PET/CT imaging reached 100%. [18F]DCFPyL PET/CT imaging ...

Highlights · Re-biopsy of obvious, peripheral, negatively biopsied PI-RADS-4-lesions is recommended. · Negatively biopsied transition zone confined PI-RADS-4- ...

Texture analysis based on PI-RADS 4/5-scored magnetic resonance images combined with machine learning to distinguish benign lesions from prostate cancer.

30 апр. 2024 г. · Treatments for stage 4 prostate cancer may slow the cancer and extend your life. But stage 4 prostate cancer often can't be cured.